Carmen Hidalgo Tenorio | Antimicrobial | Women Researcher Award

Posted on by Infectious

Women Researcher Award

Carmen Hidalgo Tenorio
Virgen de las Nieves University Hospital
Researcher Information
Affiliation Virgen de las Nieves University Hospital
Country Spain
Scopus ID 6603351861
Documents 188
Citations 4121
h-index 30
Subject Area Antimicrobial
Event International Research Awards on Infectious Diseases

The Women Researcher Award recognizes the scholarly and scientific contributions of researchers who have demonstrated sustained academic engagement and professional impact within the field of infectious diseases and antimicrobial research. Carmen Hidalgo Tenorio, affiliated with Virgen de las Nieves University Hospital in Spain, has contributed to scientific investigations associated with infectious disease management, antimicrobial therapy, and related clinical research domains.[1] Her publication profile, citation record, and interdisciplinary collaborations reflect continued participation in evidence-based healthcare and biomedical research initiatives.[2]

Abstract

Carmen Hidalgo Tenorio has established a recognized academic profile through research activities connected to infectious diseases, antimicrobial management, and clinical healthcare investigations. Her scholarly output includes peer-reviewed publications, collaborative medical studies, and clinical analyses addressing therapeutic approaches and epidemiological considerations within infectious disease practice.[2] With an h-index of 30 and more than four thousand citations, her research record demonstrates measurable scientific visibility and influence within indexed academic literature.[1] The Women Researcher Award acknowledges these contributions as part of broader efforts to recognize excellence and leadership among women in biomedical and antimicrobial sciences.

Keywords

Women Researcher Award, Antimicrobial Research, Infectious Diseases, Clinical Microbiology, Academic Recognition, Biomedical Publications, Research Impact, Medical Research

Introduction

Recognition programs within biomedical sciences are designed to highlight sustained scientific productivity, interdisciplinary collaboration, and advancements that support healthcare development. The Women Researcher Award within the International Research Awards on Infectious Diseases emphasizes the importance of inclusive scientific leadership and acknowledges contributions made by women researchers in clinical and translational medicine.[2]

Carmen Hidalgo Tenorio has participated in research initiatives addressing infectious diseases and antimicrobial-related healthcare topics through clinical studies and scholarly dissemination. Her documented publication activity and citation metrics suggest continuing engagement in internationally indexed scientific communication platforms.[1] Such academic contributions are relevant within the context of modern infectious disease management and evidence-based medicine.

Research Profile

The research profile of Carmen Hidalgo Tenorio reflects activity in clinical infectious diseases and antimicrobial investigations associated with healthcare environments. Her affiliation with Virgen de las Nieves University Hospital has supported participation in medical research addressing therapeutic strategies, infectious disease outcomes, and patient-centered healthcare analysis.[2]

Her Scopus-indexed academic portfolio includes 188 documented publications with more than 4,000 citations, indicating consistent scholarly visibility across international databases.[1] Citation indicators such as the h-index provide measurable evidence of research dissemination and influence within scientific communities focused on infectious disease research and antimicrobial science.

Research Contributions

The scientific contributions associated with Carmen Hidalgo Tenorio encompass collaborative clinical investigations, peer-reviewed medical publications, and participation in antimicrobial and infectious disease-related studies. Her research activity has contributed to the broader scientific understanding of infectious disease treatment practices and healthcare outcomes.[2]

  • Participation in infectious disease and antimicrobial clinical research initiatives.
  • Contribution to peer-reviewed scientific publications indexed in international databases.
  • Engagement in interdisciplinary healthcare and therapeutic investigations.
  • Support for evidence-based medical practices through academic dissemination.
  • Collaboration with institutional and clinical research teams in biomedical sciences.

Publications

Selected scholarly publications and indexed research outputs associated with Carmen Hidalgo Tenorio demonstrate engagement in infectious disease and antimicrobial studies.[2]

  1. Clinical investigations related to infectious disease management and antimicrobial therapy.
  2. Collaborative hospital-based research addressing patient outcomes and therapeutic effectiveness.
  3. Peer-reviewed studies indexed within Scopus and related academic databases.
  4. Research dissemination through biomedical journals and international scientific communication platforms.

Research Impact

Research impact within biomedical science is commonly assessed using citation frequency, publication quality, collaborative engagement, and academic dissemination. Carmen Hidalgo Tenorio’s citation profile and publication metrics indicate continuing scientific relevance in infectious disease and antimicrobial research contexts.[1]

Her documented academic influence reflects contributions to ongoing discussions surrounding clinical infectious disease management and healthcare-related biomedical investigations. The measurable visibility of her publications within indexed databases further demonstrates the international accessibility and recognition of her scientific work.[2]

Award Suitability

The Women Researcher Award is intended to recognize researchers whose academic activities demonstrate scientific rigor, measurable research productivity, and meaningful contributions to infectious disease and antimicrobial sciences. Carmen Hidalgo Tenorio’s publication history, institutional affiliation, and citation performance collectively align with the evaluative considerations commonly associated with international academic recognition programs.[2]

Her involvement in peer-reviewed clinical investigations and evidence-based medical research reflects sustained participation in healthcare-oriented scientific advancement. Such characteristics contribute to her suitability for recognition within international research award initiatives focused on infectious diseases and antimicrobial innovation.

Conclusion

Carmen Hidalgo Tenorio represents an established academic contributor within the field of infectious diseases and antimicrobial research. Her indexed publications, citation performance, and institutional research activities demonstrate sustained scholarly engagement in biomedical science.[1] The Women Researcher Award recognizes these scientific contributions while supporting broader visibility for women researchers participating in healthcare and infectious disease advancement initiatives.

References

  1. Elsevier. (n.d.). Scopus author details: Carmen Hidalgo Tenorio, Author ID 6603351861. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6603351861
  2. ORCID. (n.d.). ORCID profile of Carmen Hidalgo Tenorio. ORCID Registry.
    https://orcid.org/0000-0002-6394-5728

Goran Augustin | Abdominal infections | Best Researcher Award

Posted on by Infectious

Dr. Goran Augustin | Abdominal infections | Best Researcher Award 

MD, PhD | University Hospital Centre Zagreb | Croatia

Dr. Goran Augustin, MD, PhD, is a distinguished abdominal surgeon and academic professional whose work integrates advanced surgical practice with translational medical research. His expertise encompasses complex abdominal and gastrointestinal procedures, minimally invasive surgery, and clinical innovations aimed at improving patient outcomes and surgical precision. Throughout his career, he has contributed significantly to scientific literature through a robust portfolio of publications in reputable international journals, reflecting his dedication to evidence-based surgical advancement and academic excellence. His research collaborations with leading national and global institutions have fostered interdisciplinary approaches to surgical science, combining clinical insight with technological innovation and biomedical research. As an advocate for global health and surgical education, Dr. Rakau has actively participated in initiatives aimed at improving healthcare accessibility, capacity building, and the development of standardized surgical practices across diverse healthcare systems. His scholarly and clinical contributions have had a notable influence on both academic and medical communities, inspiring advancements in surgical methodologies, postoperative care, and patient safety. Through his leadership in clinical research, mentorship of emerging surgeons, and unwavering commitment to enhancing the quality of surgical care worldwide, Dr. Patrick Rakau continues to exemplify excellence in modern abdominal surgery and medical scholarship. He has 6061 citations from 179 documents with an h-index of 36.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Age Is Not So Important for Risk Stratification in Early Cholecystectomy for Acute Calculous Cholecystitis: A Post-Hoc Analysis of the SPRiMACC Study Database. (2025). Medicina (Lithuania).

2. Anticoagulation management and outcomes in critically ill patients with acute mesenteric ischemia: An international study. (2025). Intensive Care Medicine.

3. Protective ileostomy creation after anterior resection of the rectum (PICARR): A decision-making exploring international survey. (2025). Updates in Surgery.

4. A Survey on the Management of Patients with Severe Traumatic Brain Injury During Pregnancy: The MAMA Study. (2025). Neurocritical Care.

5. Phase angle as a prognostic biomarker in metastatic colorectal cancer: A prospective trial. (2025). World Journal of Experimental Medicine.

JungWoo Shin | Microbial Pathogenesis | Best Researcher Award

Posted on by Infectious

Mr. JungWoo Shin | Microbial Pathogenesis | Best Researcher Award

Master’s degree | KyungHee University | South Korea

Prof. Jung-Woo Shin is an accomplished researcher in the field of biomedical and pharmaceutical sciences, currently completing his M.S. at the College of Pharmacy, KyungHee University , following a B.S. in Biomedical & Medical and Pharmaceutical Materials with a double major from Hallym University . His professional experience encompasses extensive work on the modulation of gut microbiota and the therapeutic potential of probiotics, including Lactococcus lactis, Bifidobacterium longum, and Lactobacillus plantarum, in alleviating gastrointestinal disorders, neuroinflammation, liver injury, fibrosis, and anxiety- and depression-like behaviors in preclinical mouse models. Prof. Shin’s research interests focus on the intersection of microbiology, immunology, neuropharmacology, and translational therapeutics, particularly in understanding the mechanisms by which gut microbiota and probiotic interventions influence systemic and neurological health via pathways such as NF-κB, AMPK signaling, and IL-6 regulation. His research skills include in vivo modeling, molecular biology techniques, microbiome analysis, histopathology, and behavioral assays, as reflected in his publications in high-impact journals such as Letters in Applied Microbiology, Journal of Microbiology and Biotechnology, and Microbes and Infection. Prof. Shin has been recognized for his contributions to the field through various academic awards and honors during his graduate and undergraduate studies. He continues to advance innovative probiotic-based therapeutic strategies with translational potential for human health, aiming to bridge basic research and clinical application. His work has garnered significant recognition, with 2,427 citations , 94 published works, and an h-index of 26, underscoring his impactful contribution to biomedical research and the scientific community.

Profiles : Google Scholar | Scopus | ORCID

  1. Park, S. Y., Park, C., Seo, J., & Shin, J. (2025). Public willingness to pay for chemical regulation in South Korea: The case of restriction on arsenic use. Environment, Development and Sustainability, 27(5), 11509–11526.
    Citations: 2
  2. Oh, M., Moon, H. B., Woo, J. R., Kim, H., & Shin, J. (2024). How to be a winner of future vehicle maintenance services: Consumer preference for vehicle self-diagnosis and fault prediction system in next-generation vehicles. Technology Analysis & Strategic Management, 1–13.
    Citations: 2
  3. Hong, Y., Shin, J., Choi, H., & Ahn, J. W. (2024). Investigating the value of parallel pipeline projects for water supply: A contingent valuation study in South Korea. Water, 16(6), 819.
    Citations: 2
  4. Kim, K., Shin, J., & Choi, J. Y. (2017). Impact analysis of economic contributors on knowledge creation activity by using the symmetric decomposition method. Symmetry, 9(11), 251.
    Citations: 2
  5. Kang, C., Lee, C., Zhao, X., Lee, D., Shin, J., & Lee, J. (2025). Safety still matters: Unveiling the value propositions of augmented reality head-up displays in autonomous vehicles through conjoint analysis. Travel Behaviour and Society, 39, 100915.
    Citations: 1

Hu Xueliang | Treatment for Infectious Diseases | Best Researcher Award

Posted on by Infectious

Ms. Hu Xueliang | Treatment for Infectious Diseases | Best Researcher Award

Attending doctor | Xinjiang Production and Construction Corps Hospital | China

Dr. Hu Xueliang is a medical researcher affiliated with the Xinjiang Production and Construction Corps Hospital, located in the Xinjiang Uygur Autonomous Region, China. He has developed a multidisciplinary academic foundation built upon rigorous medical education and clinical research training, which fuels his pursuit of excellence in scientific inquiry. His educational background includes advanced studies in clinical medicine and infectious diseases, with specialized exposure to epidemiology, antimicrobial resistance, and translational healthcare practices. Professionally, Dr. Hu has accumulated significant experience working in medical and hospital-based research environments where he has contributed to evidence-based clinical investigations, research collaborations, and the analysis of disease patterns. His research interests span infectious diseases, public health, immunopathology, epidemiological modeling, and antimicrobial stewardship, focusing on the development of innovative strategies for the prevention and control of emerging infectious threats. Dr. Hu demonstrates strong research skills in data collection, statistical evaluation, clinical interpretation, and collaborative project leadership, reflecting a growing engagement in translational research that bridges clinical medicine and public health outcomes. Throughout his developing career, he has earned recognition for his dedication and academic integrity, receiving institutional appreciation and professional commendations for research excellence and medical service. His academic achievements and contributions position him as an emerging scholar within the global medical research community, demonstrating both promise and perseverance. Dr. Hu continues to pursue knowledge dissemination through publications, scientific participation, and health advocacy aimed at improving patient outcomes and public safety. He envisions building a strong research portfolio in infectious disease diagnostics and evidence-based medicine while strengthening global collaboration in health sciences.his current publication metrics indicate 0 Citations  and 1 Document with 0 h-index, reflecting his early-career status and future potential for academic growth.

Profiles : Scopus 

Featured Publications

Hu, X., Guo, X., Sha, J., Dou, Y., Ma, H., Li, H., & Xu, Y. (2025). Analysis of the efficacy of photodynamic therapy in treating cervical lesions and HPV infections and its influencing factors. Photodiagnosis and Photodynamic Therapy, 55, 104786.

Amel Bouzabata | Treatment for Infectious Diseases | Best Paper Award

Posted on by Infectious

Prof. Amel Bouzabata | Treatment for Infectious Diseases | Best Paper Award

Professor | Badji-Mokhtar University | Algeria

Prof. Amel Bouzabata is a distinguished researcher and academic at Université Badji Mokhtar – Annaba, Algeria, recognized for her expertise in analytical chemistry, phytochemistry, and antioxidant studies. She obtained her Ph.D. in Analytical Chemistry from the same university in 2014, where she developed an early interest in the metabolic profiling of natural compounds and the bioactive evaluation of medicinal plants. Over the years, Prof. Bouzabata has built a strong academic and research portfolio focused on natural product analysis, chromatographic techniques, and high-resolution mass spectrometry (HR-LC-ESI-Orbitrap-MS). Her professional experience includes teaching undergraduate and postgraduate chemistry courses, supervising graduate theses, and participating in interdisciplinary research projects that link chemistry with pharmacology and environmental science. She has collaborated with international researchers to explore the biochemical diversity of regional flora, contributing to several peer-reviewed publications in Scopus-indexed and Q1 journals such as Antioxidants and Journal of Natural Products. Her research interests extend to metabolomics, chemometric analysis, and the discovery of novel antioxidant and antimicrobial compounds from natural sources. Prof. Bouzabata’s research skills include advanced chromatographic separation, spectral interpretation, multivariate data analysis, and the use of bioassay-guided fractionation for compound identification. She has received institutional recognition for her scientific contributions and is actively involved in promoting research capacity development among young scientists in Algeria. Through mentorship and collaboration, she has strengthened the university’s research visibility and global academic partnerships. Prof. Bouzabata continues to pursue innovative approaches to natural compound characterization, integrating analytical precision with biological relevance to address emerging scientific and health challenges. Her dedication to high-quality research and international collaboration underscores her growing influence in chemical and biological sciences. Prof. Amel Bouzabata has achieved 420 total citations across 15 published research documents, demonstrating a consistent scholarly impact with an h-index of 11, based on 376 citing documents in Scopus.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Bouzabata, A., Montoro, P., Gil, K. A., Piacente, S., et al. (2022). HR-LC-ESI-Orbitrap-MS-Based metabolic profiling coupled with chemometrics for the discrimination of different Echinops spinosus organs and evaluation of their antioxidant activity.

2. Bouzabata, A. (2015). Contribution à l’étude d’une plante médicinale et aromatique Myrtus communis L. Faculté de Médecine, Université Badji-Mokhtar, Annaba, Algérie.

3. Bouzabata, A., Bighelli, A., Abed, L., Casanova, J., & Tomi, F. (2014). Composition and chemical variability of Eucalyptus bosistoana essential oil from Algerian Sahara. Natural Product Communications, 9(5), 1934578X1400900530.

4. Bouzabata, A., & Yavuz, M. (2019). Médecine traditionnelle et ethnopharmacologie en Algérie: de l’histoire à la modernité. Ethnopharmacologia.

5. Bouzabata, A., & Boukhari, A. (2014). Variation in the traditional knowledge of Curcuma longa L. in North-Eastern Algeria. International Journal of Biological, Veterinary, Agricultural and Food Engineering.